---
title: "ZheJiang Tailin Bioengineering Co.,Ltd (300813.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300813.SZ.md"
symbol: "300813.SZ"
name: "ZheJiang Tailin Bioengineering Co.,Ltd"
industry: "Life Sciences Tools and Services"
datetime: "2026-05-21T21:39:20.047Z"
locales:
  - [en](https://longbridge.com/en/quote/300813.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300813.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300813.SZ.md)
---

# ZheJiang Tailin Bioengineering Co.,Ltd (300813.SZ)

## Company Overview

Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. It also provides pharma processing, such as pharma isolators, high-precision filling and dispensing, sterile transfer; cell and gene therapy; radiopharma; laboratory animal; leak test systems; biodecontamination, including VH2O2 sterilization system and dry fogging system; sterilization monitoring and validation; microbiological testing, comprising sterility and microbial limit test system and pretreatment instruments; and water quality, consisting of microbial monitoring and aquatic organism detection system, total organic carbon (TOC) analysis, enzyme substrate method, and automatic detection system for cryptosporidium and giardia. In addition, the company offers filtration membranes, such as flat and blotting membranes, IVD series, membrane filters and dispensers; and analytical instruments, including filter integrity testing, container closure integrity testers (CCIT), water activity meters, and biodegradation analysis systems.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.tailingood.com](https://www.tailingood.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: C (0.45)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 20 / 26 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.71% |  |
| Net Profit YoY | 26.32% |  |
| P/B Ratio | 3.66 |  |
| Dividend Ratio | 0.94% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2944317932.73 |  |
| Revenue | 338886113.66 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.03% | C |
| Profit Margin | 4.86% | C |
| Gross Margin | 44.28% | B |
| Revenue YoY | -2.71% | D |
| Net Profit YoY | 26.32% | B |
| Total Assets YoY | -0.10% | D |
| Net Assets YoY | -2.00% | D |
| Cash Flow Margin | 289.48% | A |
| OCF YoY | -2.71% | D |
| Turnover | 0.35 | D |
| Gearing Ratio | 16.13% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - ZheJiang Tailin Bioengineering Co.,Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.71%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "26.32%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.66",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.94%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2944317932.73",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "338886113.66",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.03%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "4.86%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "44.28%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-2.71%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "26.32%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.10%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.00%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "289.48%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-2.71%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.35",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "16.13%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 159.21 | 19/26 | 229.48 | 201.25 | 187.75 |
| PB | 3.51 | 15/26 | 4.55 | 3.96 | 3.56 |
| PS (TTM) | 8.27 | 18/26 | 11.08 | 9.74 | 8.66 |
| Dividend Yield | 0.98% | 4/26 | 0.78% | 0.70% | 0.46% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300813.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300813.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300813.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300813.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**